Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 10, 2001

View Archived Issues

Proneuron and Teva to collaborate on development of glatiramer acetate as neuroprotective agent

DSMB recommends that phase III Theratope study continue

Purdue develops abuse-resistant analgesic

MedImmune set to acquire Aviron in USD 1.5 billion deal

Final phase IIb results of IL-2 GeneMedicine product disappointing

Oral cromolyn sodium shows good GI absorption in conjunction with Emisphere technology

FDA approval for intravenous formulation of Avelox

Antizol receives additional approval in Canada for methanol poisoning

Shire will not exercise Cytovax MAb product option; continues Cytovaxine development

Enrollment completed for phase II trial of ZYC-101a in HPV-associated cervical dysplasia

Incara and FDA meet to discuss plans for liver cell program prior to IND submission

Amgen's OPG as effective as pamidronate in reducing bone resorption in multiple myeloma patients

Sugen presents in vitro data on indolinone related to SU-5416 at Hematology meeting

RWJ-58259 effectively blocks thrombosis in primate model

Merger of Nippon Roche and Chugai scheduled for next year

Promise of plant extract in sickle cell disease therapy upheld by preclinical data

PSC-833, an MDR modulator, examined in untreated AML patients of different age groups

Tubulin polymerization inhibitor effective against refractory tumors in clinical trials

Safety data from phase II trial in lymphoma patients reported for apolizumab

FDA lifts hold on phase III trial of Aptosyn + Taxotere

Proof-of-principle study completed for P-57 as treatment for obesity

New histamine H3 receptor ligands designed by Ortho-McNeil

Inhibitors of SGLT2 under study at BMS as potential antidiabetic agents

Peptides binding CEA useful for imaging and treating tumors

Takeda scientists identify compounds which increase sAPP secretion

Highly potent and nontoxic TNF-alpha production inhibitors reported by Sankyo

Herpesvirus polymerase inhibitors described in recent patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....